Ir para o conteúdo principal
Grafa
Cal-Maine profits tumble as egg prices normalize, firm bets big on specialty shift
Image for illustrative purposes only. Not a real photo.

Cal-Maine profits tumble as egg prices normalize, firm bets big on specialty shift

Share

Cal-Maine Foods (NASDAQ:CALM) reported a sharp decline in second-quarter earnings on Wednesday, January 7, 2026, as the primary U.S. egg producer grapples with a retreat from the record-high commodity prices that fueled prior windfalls.

Net income for the quarter ended November 29, 2025, fell 53.1% to $102.8 million, or $2.13 per diluted share, missing the triple-digit gains seen during the peak of the avian flu supply crunch in fiscal 2025.

Net sales dropped 19.4% to $769.5 million, primarily driven by a 41% plunge in conventional egg revenue.

Despite the top-line pressure, management is aggressively pivoting the company’s portfolio toward higher-margin "value-added" products.

Specialty eggs—including organic, cage-free, and pasture-raised—now account for a record 44% of total shell egg sales, up significantly from a year ago.

The company also announced a $36 million investment to expand its prepared foods capacity by 30%, aiming to capture a larger share of the ready-to-eat protein market through its recently acquired Echo Lake Foods and Crepini brands.

Meanwhile, Cal-Maine remains financially robust, finishing the quarter with zero debt and a strong cash position.

The board declared a cash dividend of $0.72 per share, payable in February, alongside $74.8 million in share repurchases completed during the quarter.

To further bolster its specialty supply chain, the company confirmed the acquisition of Clean Egg production assets, ensuring a steady flow of free-range and cage-free supply as state-level mandates and consumer preferences continue to shift away from caged production.